Dr. Suresh Yerra
Heart valve diseases can gradually affect the heart’s ability to pump blood efficiently, often leading to breathlessness, fatigue, and reduced quality of life. One of the most common valve-related problems is mitral regurgitation, a condition in which the mitral valve does not close properly, allowing blood to leak backwards inside the heart.
Advances in interventional structural cardiology have taken us far from traditional open-heart surgical solutions and have now made it possible to treat patients with less invasive techniques such as the MitraClip procedure. This has emerged as an important treatment option for patients with severe mitral regurgitation who are considered high-risk for conventional surgery.
The mitral valve is located between the left upper chamber and the left lower chamber of the heart. Its role is to ensure blood flows in the correct direction. In mitral regurgitation, the valve becomes weak or damaged and fails to close completely. As a result, blood leaks backwards into the heart instead of moving efficiently to the rest of the body. Over time, this forces the heart to work harder and may eventually lead to heart failure if left untreated.
Common symptoms of mitral regurgitation include:
Some patients may not experience symptoms during the early stages, which is why regular cardiac evaluation is important for individuals with known valve disease.
The MitraClip procedure is a minimally invasive treatment used to repair a leaking mitral valve without open-heart surgery. The treatment is performed using a catheter-based technique known as Transcatheter Edge-to-Edge Repair (TEER).
During the procedure, a thin flexible tube passes through a blood vessel in the groin and guides it to the heart. A small clip device is then attached to the mitral valve leaflets to help them close more effectively and reduce blood leakage. Unlike conventional surgery, the chest does not need to be opened, and the heart usually continues beating during the procedure, which generally takes between one and three hours. Since it avoids large surgical incisions, patients often experience faster recovery compared to conventional surgery.
The MitraClip procedure is generally recommended for patients with severe symptomatic mitral regurgitation who may not be ideal candidates for open-heart surgery due to age, weak body, or other medical conditions.
Before recommending the procedure, cardiologists perform a detailed assessment that may include:
Echocardiography (Including Trans Esphageal ECHO)
CT scans
Cardiac catheterisation
Blood investigations
Heart rhythm evaluation
Overall surgical risk assessment
Doctors also evaluate the structure and anatomy of the mitral valve to determine whether the clip can be safely and effectively placed.
MitraClip offers several advantages for carefully selected patients, especially those who are at high surgical risk. Some important benefits include:
Many patients notice symptom relief soon after the procedure and are able to gradually return to routine activities within a few weeks.
Recovery is generally quicker compared to traditional open-heart surgery. Most patients remain in the hospital for observation for one to three days, depending on their condition and overall recovery.
After discharge, patients are advised to:
Regular follow-up imaging may also be recommended to assess valve function and long-term heart health.
Like any heart procedure, MitraClip carries certain risks, although it is considered safe when performed by experienced cardiac specialists. Possible complications may include:
Careful patient selection and advanced imaging technology have significantly improved procedural success and outcomes over the years.
At STAR Hospitals, patients with complex heart valve disorders receive comprehensive evaluation and advanced cardiac care through multidisciplinary heart teams that include interventional cardiologists, cardiac surgeons, imaging specialists, anaesthetists, and critical care experts.
Our cardiac sciences departments are equipped with advanced catheterisation laboratories, modern imaging systems, and minimally invasive treatment capabilities for structural heart conditions such as mitral valve disease and aortic valve disorders. From diagnosis and risk assessment to procedure planning, post-operative monitoring, and rehabilitation, STAR Hospitals focuses on delivering patient-centred cardiac care with an emphasis on precision, safety, and recovery.
The MitraClip procedure has expanded treatment possibilities for patients with severe mitral regurgitation who may not be suitable candidates for open-heart surgery. By combining advanced imaging, catheter-based technology, and minimally invasive techniques, the procedure helps reduce symptoms and improve quality of life with shorter recovery times. As structural heart interventions continue to advance, treatments like MitraClip are helping more patients receive effective cardiac care with greater comfort and confidence.
DR. M. HANUMANTHA REDDY | MAY 23, 2026
Minimally Invasive Cardiac Procedures: The Latest Advances in Cardiac Care
Terms & Conditions | Privacy Policy | Cancellation and Refund Policy | © 2008-2026 Star Hospitals, All Rights Reserved